Your session is about to expire
← Back to Search
REST Trial Summary
This trial is looking at whether or not the REST model can help older adults with type 1 or type 2 diabetes adopt and sustain continuous glucose monitoring (CGM). The REST model is a patient-centered model that focuses on providing resources and support to patients to help them manage their diabetes. The trial will also look at the impact of the REST model on economic factors and quality of life measures.
REST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowREST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.REST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I take more than 4 grams of acetaminophen daily.I use a hybrid closed-loop system for my condition.I take insulin more than 3 times a day or use an insulin pump.I have had type 1 or type 2 diabetes for over a year.My blood sugar often drops below 70 mg/dL or stays within 70-180 mg/dL less than 40% of the time.My kidney function is severely reduced.You have difficulty seeing and hearing, which would make it hard for you to take part in video calls.I use or have never used a CGM but my blood sugar levels are not on target.I am taking hydroxyurea which affects my Dexcom G6 sensor readings.You are expected to live less than 1 year.I am 65 years old or older.
- Group 1: Single Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the major goals of this trial?
"This trial, which will span baseline to 6 months, has two primary implementation outcomes. Additionally, it aims to measure the amount of time spent in hypoglycemia (sensor glucose <70 mg/dL), visits needed for CGM use initiation and maintenance, as well as cost-effectiveness ratios compared with standard care."
Is enrollment still available for this clinical trial?
"Affirmative. The clinicaltrials.gov portal states that this trial is actively seeking patients for enrollment, with the study being first posted on April 20th 2022 and recently updated on September 15th 2022. The research team seeks to recruit 120 participants from two distinct sites."
What is the current population of participants in this research?
"Affirmative, clinicaltrials.gov data indicates that this investigation is actively seeking participants. It was initially listed on April 20th 2022 and the details were most recently revised on September 15th 2022. The trial requires 120 individuals from two medical centres to take part."
Share this study with friends
Copy Link
Messenger